癌变·畸变·突变 ›› 2008, Vol. 20 ›› Issue (4): 325-327.doi: 10.3969/j.issn.1004-616x.2008.04.020

• 检测研究 • 上一篇    下一篇

复脑苏对孕鼠致畸性的研究

朱玉平1/ 马玺里1/ 张天宝1/ 万旭英1/ 郑怡文1/ 毕 洁1/ 郭美丽2/ 朱江波1   

  1. 1.第二军医大学卫生毒理学教研室,上海 200433;2.第二军医大学药学院生药教研室,上海 200433
  • 收稿日期:2007-10-23 修回日期:2007-12-13 出版日期:2008-07-30 发布日期:2008-07-30

Study on Teratogenicity of Carthami in Pregnant SD Rats

ZHU Yu_ping1, MA Xi_li1, ZHANG Tian_bao1, WAN Xu_ying1, ZHENG Yi_wen1, BI Jie1, GUO Mei_li2, ZHU Jiang_bo1,   

  1. 1. Department of Health Toxicology, Second Military Medical University, Shanghai 200433; 2. Department of Pharmacognosy,School of Pharmacy,Second Military Medical University, Shanghai 200433; China
  • Received:2007-10-23 Revised:2007-12-13 Online:2008-07-30 Published:2008-07-30

摘要: 背景与目的: 评价复脑苏在妊娠期的毒性。 材料与方法: 用82只SD大鼠孕鼠,分为3个不同剂量的复脑苏(7.5 mg/kg、 15.0 mg/kg、30.0 mg/kg )实验组,同时设阴性对照组(0.85% NS),每组19~21只孕鼠,实验组和对照组给药容量为10 ml/kg体重。实验组和阴性对照组均采用尾静脉给药,给药时间为妊娠期第6 d~15 d。于妊娠第20 d处死孕鼠,检查妊娠母体与胎鼠畸形情况。 结果: 复脑苏在各剂量组的活胎率、死胎率和吸收胎率及致畸率与对照组相比较差异无统计学意义(P>0.05);各实验组胎鼠体重、身长、尾长与对照组比较差异也无统计学意义(P>0.05);实验组的平均胎盘重与对照组相比较差异均具有统计学意义(P<0.05),但无明显的剂量_效应关系。各实验组除尾椎数和远端趾骨数与对照组相比差异具有统计学意义外(P<0.05),其它骨骼发育与对照组比较差异均无统计学意义(P>0.05)。各实验组均未观察到母鼠和胎鼠明显的外观、脏器以及骨骼的畸形。 结论: 复脑苏在本实验剂量(≤30.0 mg/kg)下无明显的母鼠毒性和致畸作用,也无明显的胚胎毒性和胎鼠毒性。

关键词: 复脑苏, 母体毒性, 致畸作用, 胚胎毒性, 胎儿毒性

Abstract: BACKGROUND AND AIM:To study the teratogenic toxicities of carthamus in SD rats during the period of organ formation. MATERIALS AND METHODS: Eighty_two pregnant SD rats were randomly divided into four groups with about 20 rats in each, three carthamus dosage groups (7.5,15.0,30.0 mg/kg),and one negative control group. carthamus or normal saline was given via vena caudalis injection for 10 days during the period of organ formation (the 6th to 15th day of gestation). The rats were sacrificed to examine the fetuses on the 20th day. RESULTS: Carthamus didn't produce significant difference on living fetuses ratio, absorbed fetuses ratio, dead fetus ratio, body length, tail length and weight of fetuses .There were statistical differences on average weight of placenta ,number of caudal vertebra and distant digital bone between treated groups and the negative control group. It didn' t induce any teratogenic effect on the appearance, bones and bowels of the fetuses when used under 30.0 mg/kg. CONCLUSION: Carthamus had no maternal toxicity, teratogenic toxicity, embryotoxicity and fetotoxicity when used under 30.0 mg/kg.

Key words: carthamus, maternal toxicity, teratogenesis, embryotoxicity, fetotoxicity